FDA Unveils Proposal For Streamlined De Novo Reviews
10.10.11
Publication: The Gray Sheet By:
Despite statutory constraints, FDA is hoping to trim as many as 90 days off the total review process for de novo petitions.
The agency outlined its proposed administrative changes in a Sept. 30 draft guidance on the de novo review program.
New Data Shows Decline in Medical Imaging Utilization
A new analysis of Medicare data finds that spending on medical imaging continues to decline and that Medicare patients are receiving fewer imaging procedures. Learn More
MITA Now Includes Radiopharmaceutical Industry in Membership
With new membership MITA unites both halves of nuclear medicine. Learn More
CT Lung Cancer Screening Named Top Five Advance in 2011
The American Society of Clinical Oncology (ASCO) named CT-based lung cancer screening amongst 2011’s top five advances in its annual report on progress against cancer. Learn More
- © 2012 National Electrical Manufacturers Association |
- Privacy Policy |
- Terms & Conditions